The kinase domain of death-associated protein kinase is inhibitory for tubulointerstitial fibrosis in chronic obstructive nephropathy

  • Authors:
    • Kazunori Yukawa
    • Masanori Kishino
    • Katsuaki Hoshino
    • Nobuyuki Shirasawa
    • Akihiko Kimura
    • Yuji Tsubota
    • Kyoko Owada-Makabe
    • Tao Bai
    • Tetsuji Tanaka
    • Takashi Ueyama
    • Masakazu Ichinose
    • Kiyoshi Takeda
    • Shizuo Akira
    • Masanobu Maeda
  • View Affiliations

  • Published online on: January 1, 2005     https://doi.org/10.3892/ijmm.15.1.73
  • Pages: 73-78
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Death-associated protein kinase (DAPK) is a Ca2+/calmodulin-dependent serine/threonine kinase that is thought to mediate apoptosis. We have shown that the kinase domain of DAPK is crucial for the induction of renal tubular cell apoptosis in chronic obstructive uropathy (COU) created by unilateral ureteral ligation. DAPK-mutant mice, generated by deletion of 74 amino acids from the catalytic kinase domain, were used to investigate the role of the DAPK kinase domain in renal fibrosis following COU. Interstitial collagen and α-smooth muscle actin (α-SMA) expressions in situ were compared between obstructed kidneys in wild-type and mutant mice. As a result, tubulointerstitial fibrosis, as quantified by interstitial collagen expression, was significantly augmented in mutant kidneys compared with wild-type kidneys following COU. Furthermore, deletion of the kinase domain from DAPK significantly increased the appearance of α-SMA-positive myofibroblasts in the renal interstitium during COU. Thus, our results suggest that the kinase domain deleted by gene targeting plays a suppressive role for the development of renal fibrosis through inhibition of the tubular epithelial-to-mesenchymal transition in a mouse model of COU.

Related Articles

Journal Cover

January 2005
Volume 15 Issue 1

Print ISSN: 1107-3756
Online ISSN:1791-244X

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Yukawa K, Kishino M, Hoshino K, Shirasawa N, Kimura A, Tsubota Y, Owada-Makabe K, Bai T, Tanaka T, Ueyama T, Ueyama T, et al: The kinase domain of death-associated protein kinase is inhibitory for tubulointerstitial fibrosis in chronic obstructive nephropathy. Int J Mol Med 15: 73-78, 2005.
APA
Yukawa, K., Kishino, M., Hoshino, K., Shirasawa, N., Kimura, A., Tsubota, Y. ... Maeda, M. (2005). The kinase domain of death-associated protein kinase is inhibitory for tubulointerstitial fibrosis in chronic obstructive nephropathy. International Journal of Molecular Medicine, 15, 73-78. https://doi.org/10.3892/ijmm.15.1.73
MLA
Yukawa, K., Kishino, M., Hoshino, K., Shirasawa, N., Kimura, A., Tsubota, Y., Owada-Makabe, K., Bai, T., Tanaka, T., Ueyama, T., Ichinose, M., Takeda, K., Akira, S., Maeda, M."The kinase domain of death-associated protein kinase is inhibitory for tubulointerstitial fibrosis in chronic obstructive nephropathy". International Journal of Molecular Medicine 15.1 (2005): 73-78.
Chicago
Yukawa, K., Kishino, M., Hoshino, K., Shirasawa, N., Kimura, A., Tsubota, Y., Owada-Makabe, K., Bai, T., Tanaka, T., Ueyama, T., Ichinose, M., Takeda, K., Akira, S., Maeda, M."The kinase domain of death-associated protein kinase is inhibitory for tubulointerstitial fibrosis in chronic obstructive nephropathy". International Journal of Molecular Medicine 15, no. 1 (2005): 73-78. https://doi.org/10.3892/ijmm.15.1.73